Xiaozhang Xu

695 total citations · 1 hit paper
7 papers, 331 citations indexed

About

Xiaozhang Xu is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiaozhang Xu has authored 7 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Xiaozhang Xu's work include Immune cells in cancer (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Xiaozhang Xu is often cited by papers focused on Immune cells in cancer (4 papers), Immune Cell Function and Interaction (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Xiaozhang Xu collaborates with scholars based in China, Bangladesh and United States. Xiaozhang Xu's co-authors include Xiangyü Li, Qiuyang Chen, Bo Zhou, Jinren Zhou, Qi Wang, Qing Shao, Haoming Zhou, Ling Lü, Jian Gu and Ji Gao and has published in prestigious journals such as Oncogene, Scientific Reports and Cell Reports.

In The Last Decade

Xiaozhang Xu

6 papers receiving 330 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells

2022 298 citations Jian Gu, Jinren Zhou et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaozhang Xu China	4	181	162	119	61	29	7	331
Dimitris C. Kanellis Denmark	10	209 1.2×	88 0.5×	62 0.5×	85 1.4×	31 1.1×	14	323
Ana Rita Lourenço Netherlands	9	238 1.3×	106 0.7×	84 0.7×	90 1.5×	38 1.3×	11	383
Tzu-Sheng Hsu Taiwan	9	128 0.7×	84 0.5×	143 1.2×	86 1.4×	24 0.8×	21	314
Ting‐Miao Wu China	12	275 1.5×	245 1.5×	48 0.4×	47 0.8×	31 1.1×	17	378
Reham Helwa Egypt	9	210 1.2×	99 0.6×	48 0.4×	75 1.2×	49 1.7×	19	322
Annika F. Fink Germany	8	167 0.9×	99 0.6×	161 1.4×	98 1.6×	18 0.6×	10	321
Mengna Zhan China	9	253 1.4×	201 1.2×	51 0.4×	77 1.3×	34 1.2×	13	367
Florinda Meléndez‐Rodríguez Spain	6	170 0.9×	135 0.8×	37 0.3×	38 0.6×	47 1.6×	6	280
Diyu Hou China	10	213 1.2×	114 0.7×	42 0.4×	57 0.9×	22 0.8×	17	334

Countries citing papers authored by Xiaozhang Xu

Since Specialization

Citations

This map shows the geographic impact of Xiaozhang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhang Xu more than expected).

Fields of papers citing papers by Xiaozhang Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhang Xu. The network helps show where Xiaozhang Xu may publish in the future.

Co-authorship network of co-authors of Xiaozhang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhang Xu. A scholar is included among the top collaborators of Xiaozhang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhang Xu. Xiaozhang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Liang, Yuan, Rui Zhang, Haijun Yu, et al.. (2025). Integrated single-cell and spatial transcriptomic profiling reveals that CD177+ Tregs enhance immunosuppression through apoptosis and resistance to immunotherapy in hepatocellular carcinoma. Oncogene. 44(21). 1578–1591. 2 indexed citations

2.

Yuan, Liang, Haijun Yu, Xiangyü Li, et al.. (2025). PSME3 drives Tregs infiltration and anti-PD1 resistance in hepatocellular carcinoma by regulating FBXL7/PTEN-mediated metabolic reprogramming. Oncogene. 44(46). 4475–4490.

3.

Bu, Qingfa, Xiaozhang Xu, Qi Wang, et al.. (2024). ATG16L1 Depletion‐Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis. Mediators of Inflammation. 2024(1). 8831821–8831821. 1 indexed citations

4.

Yue, Lei, Xiaozhang Xu, Shipeng Dai, et al.. (2023). Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization. Scientific Reports. 13(1). 14092–14092. 10 indexed citations

5.

Zhou, Jinren, Qing Shao, Yunjie Lu, et al.. (2022). Monocarboxylate transporter upregulation in induced regulatory T cells promotes resistance to anti-PD-1 therapy in hepatocellular carcinoma patients. Frontiers in Oncology. 12. 960066–960066. 16 indexed citations

6.

Gu, Jian, Jinren Zhou, Qiuyang Chen, et al.. (2022). Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Reports. 39(12). 110986–110986. 298 indexed citations breakdown →

7.

Li, Qiang, et al.. (2020). Synchronous parathyroid adenoma, papillary thyroid carcinoma and thyroid adenoma in pregnancy: A case report. World Journal of Clinical Cases. 8(21). 5426–5431. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact